Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Glimepiride (2mg) + Metformin (500mg) SR Bilayered Smart Tablet
Therapeutic Category
Antidiabetic, Diabetic, Endocrinology
Dosage Form
Tablet
Packaging Type
Blister
Packaging
10*15
Price
₹111/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Gimtype M2 Tablet is a bilayered smart formulation combining Glimepiride 2mg and Metformin 500mg in a sustained-release form. Designed to optimize glycemic control, this dual-action oral antidiabetic therapy targets multiple mechanisms involved in type 2 diabetes management. Glimepiride, a sulfonylurea, enhances insulin secretion from pancreatic beta cells, helping reduce fasting and postprandial blood glucose levels. Metformin, a biguanide, improves insulin sensitivity and decreases hepatic glucose output. The bilayered design of Gimtype M2 allows for controlled and extended release of Metformin, ensuring better gastrointestinal tolerance and more consistent blood glucose control throughout the day. This smart tablet is ideal for patients who require a more intensive glycemic management plan without increasing the pill burden.
Some patients may experience mild side effects such as nausea, abdominal discomfort, diarrhea, or dizziness. Hypoglycemia may occur, particularly if the tablet is taken without adequate food. Rare but serious risks include lactic acidosis, especially in those with renal impairment. It is important to take this medicine exactly as prescribed and report any adverse symptoms to a healthcare provider.
Gimtype M2 Tablet is indicated for adults with type 2 diabetes mellitus when lifestyle modifications and monotherapy with either Glimepiride or Metformin do not provide sufficient glycemic control. It helps reduce both fasting and post-meal blood glucose levels.
Not recommended for patients with significant renal or hepatic impairment, heart failure, or metabolic acidosis. Caution is advised in elderly patients and during times of stress such as surgery or infection. Avoid alcohol consumption while on this medication.
Store below 30°C in a dry and cool place. Protect from direct sunlight and moisture. Keep the container tightly closed and out of the reach of children.
Composition : Glimepiride (1mg) Tablet
Composition : Glimepiride (2mg) Tablet
Composition : Glimepiride 1mg + Metformin 500mg + Pioglitazone 15mg Bi-Layered Tablets
Composition : Glimepiride 2mg + Metformin Hydrochloride I.P. 500mg + Pioglitazone 15mg Bi-Layered Tablets
Composition : Dapagliflozin 10mg Tablets
Composition : Gliclazide 80mg + Metformin Hydrochloride I.P. 500mg Tablets
Composition : Empagliflozin (10mg) Tablet
Composition : Empagliflozin (25mg) Tablet
Composition : Empagliflozin (10mg) + Sitagliptin 100mg
Composition : Empagliflozin (25mg) + Sitagliptin (100mg) Tablet
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
This anti-diabetic combination is widely used in type 2 diabetes management, making it a strong prescription product for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma pharma franchise market.
Medical distributors and wholesalers can benefit from consistent demand in type 2 diabetes, fasting and post-meal blood sugar control, insulin resistance, and long-term glycemic management. It is widely prescribed by physicians and diabetologists for patients requiring dual therapy with sustained-release Metformin for improved compliance.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for Glimepiride 2mg + Metformin 500mg SR Bilayered Smart Tablet with monopoly rights, quality packaging, competitive pricing, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from strong chronic prescription demand, lifelong therapy usage, and steady monthly repeat sales in diabetes care when partnering with Cafoli Lifecare.
Medical distributors, stockists, wholesalers, and pharma professionals interested in this diabetic formulation can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, pricing, and distribution support services.